2012
DOI: 10.1007/s00398-012-0911-0
|View full text |Cite
|
Sign up to set email alerts
|

Indikationsstellung, Strukturen und Prozesse für die kathetergestützte Aortenklappenimplantation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
6
0
1

Year Published

2012
2012
2015
2015

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 16 publications
0
6
0
1
Order By: Relevance
“…We could show that the procedure was perceived as significantly better. Still, this is only true for the current indication: older patients with severe symptomatic AS who are not suited for conventional procedures [ 10 ]. Considering the age of patients undergoing TAVI, the recommendations of the national and European cardiac and cardiothoracic societies and associations suggest a minimum age of 75 [ 10 ].…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…We could show that the procedure was perceived as significantly better. Still, this is only true for the current indication: older patients with severe symptomatic AS who are not suited for conventional procedures [ 10 ]. Considering the age of patients undergoing TAVI, the recommendations of the national and European cardiac and cardiothoracic societies and associations suggest a minimum age of 75 [ 10 ].…”
Section: Discussionmentioning
confidence: 99%
“…Still, this is only true for the current indication: older patients with severe symptomatic AS who are not suited for conventional procedures [ 10 ]. Considering the age of patients undergoing TAVI, the recommendations of the national and European cardiac and cardiothoracic societies and associations suggest a minimum age of 75 [ 10 ]. In the group of patients under the age of 75, the surgical intervention was considered superior to TAVI, although the respondents predicted changing recommendations for the near future.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…27 The criticisms support the view that the technology was, and still is being, used beyond proper indications and in treatment facilities not adequately equipped for emergencies. 23 The approach of the Food and Drug Administration, which waited until the PARTNER results were available before making a decision, shows the advantages of requiring some efficacy data before approval for market. In the US, TAVI was only ever approved for a restricted group of patients.…”
Section: The Tavi Experiencementioning
confidence: 99%